{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T10:42:19Z","timestamp":1777027339921,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T00:00:00Z","timestamp":1482278400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81373188"],"award-info":[{"award-number":["81373188"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s10067-016-3510-8","type":"journal-article","created":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T23:31:33Z","timestamp":1482276693000},"page":"407-412","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Evaluation of the clinical relevance of anti-annexin-A5 antibodies in Chinese patients with antiphospholipid syndrome"],"prefix":"10.1007","volume":"36","author":[{"given":"Shulan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoting","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liubing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiuliang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengchun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,21]]},"reference":[{"key":"3510_CR1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.berh.2016.04.002","volume":"30","author":"M Khamashta","year":"2016","unstructured":"Khamashta M, Taraborelli M, Sciascia S, Tincani A (2016) Antiphospholipid syndrome. Best Pract Res Clin Rheumatol 30:133\u2013148","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"3510_CR2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295\u2013306","journal-title":"J Thromb Haemost"},{"key":"3510_CR3","doi-asserted-by":"crossref","unstructured":"Negrini S, Pappalardo F, Murdaca G, Indiveri F, Puppo F (2016) The antiphospholipid syndrome: from pathophysiology to treatment. Clin Exp Med. Accepted","DOI":"10.1007\/s10238-016-0430-5"},{"key":"3510_CR4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.autrev.2011.04.007","volume":"10","author":"L Iaccarino","year":"2011","unstructured":"Iaccarino L, Ghirardello A, Canova M et al (2011) Anti-annexins autoantibodies: their role as biomarkers of autoimmune diseases. Autoimmun Rev 10:553\u2013558","journal-title":"Autoimmun Rev"},{"key":"3510_CR5","doi-asserted-by":"crossref","first-page":"17907","DOI":"10.1016\/S0021-9258(19)37128-5","volume":"267","author":"HA Andree","year":"1992","unstructured":"Andree HA, Stuart MC, Hermens WT et al (1992) Clustering of lipid-bound annexin V may explain its anticoagulant effect. J Biol Chem 267:17907\u201317912","journal-title":"J Biol Chem"},{"key":"3510_CR6","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0002-9440(10)63479-7","volume":"163","author":"JH Rand","year":"2003","unstructured":"Rand JH, Wu XX, Quinn AS et al (2003) Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay. Am J Pathol 163:1193\u20131200","journal-title":"Am J Pathol"},{"key":"3510_CR7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJM199707173370303","volume":"337","author":"JH Rand","year":"1997","unstructured":"Rand JH, Wu XX, Andree HA et al (1997) Pregnancy loss in the antiphospholipid-antibody syndrome\u2014a possible thrombogenic mechanism. N Engl J Med 337:154\u2013160","journal-title":"N Engl J Med"},{"key":"3510_CR8","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1182\/blood-2004-01-0203","volume":"104","author":"JH Rand","year":"2004","unstructured":"Rand JH, Wu XX, Lapinski R et al (2004) Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome. Blood 104:2783\u20132790","journal-title":"Blood"},{"key":"3510_CR9","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1093\/rheumatology\/kev226","volume":"54","author":"V Rodr\u00edguez-Garc\u00eda","year":"2015","unstructured":"Rodr\u00edguez-Garc\u00eda V, Ioannou Y, Fern\u00e1ndez-Nebro A, Isenberg DA, Giles IP (2015) Examining the prevalence of non-criteria anti-phospholipid antibodies in patients with anti-phospholipid syndrome: a systematic review. Rheumatology (Oxford) 54:2042\u20132050","journal-title":"Rheumatology (Oxford)"},{"key":"3510_CR10","first-page":"1715","volume":"26","author":"A Satoh","year":"1999","unstructured":"Satoh A, Suzuki K, Takayama E et al (1999) Detection of anti-annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Rheumatol 26:1715\u20131720","journal-title":"J Rheumatol"},{"key":"3510_CR11","first-page":"924","volume":"27","author":"G Lakos","year":"2000","unstructured":"Lakos G, Kiss E, Regeczy N et al (2000) Antiprothrombin and antiannexin V antibodies imply risk of thrombosis in patients with systemic autoimmune diseases. J Rheumatol 27:924\u2013929","journal-title":"J Rheumatol"},{"key":"3510_CR12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/1756-185X.12044","volume":"16","author":"NK Singh","year":"2013","unstructured":"Singh NK, Yadav DP, Gupta A, Singh U, Godara M (2013) Role of anti-annexin A5 in pathogenesis of hypercoagulable state in patients with antiphospholipid syndrome. Int J Rheum Dis 16:325\u2013330","journal-title":"Int J Rheum Dis"},{"key":"3510_CR13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1309\/298H-NLBU-E47G-8PYL","volume":"114","author":"H Ogawa","year":"2000","unstructured":"Ogawa H, Zhao D, Dlott JS et al (2000) Elevated anti-annexin V antibody levels in antiphospholipid syndrome and their involvement in antiphospholipid antibody specificities. Am J Clin Pathol 114:619\u2013628","journal-title":"Am J Clin Pathol"},{"key":"3510_CR14","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1136\/ard.2005.045237","volume":"65","author":"B Laat de","year":"2006","unstructured":"de Laat B, Derksen RH, Mackie IJ et al (2006) Annexin A5 polymorphism (\u22121C--\u00a0>\u00a0T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome. Ann Rheum Dis 65:1468\u20131472","journal-title":"Ann Rheum Dis"},{"key":"3510_CR15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1055\/s-0037-1614001","volume":"84","author":"JC Gris","year":"2000","unstructured":"Gris JC, Qu\u00e9r\u00e9 I, Sanmarco M et al (2000) Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The N\u00eemes obstetricians and Haematologists study--NOHA. Thromb Haemost 84:228\u2013236","journal-title":"Thromb Haemost"},{"key":"3510_CR16","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1046\/j.1365-2141.2001.02812.x","volume":"113","author":"J Arnold","year":"2001","unstructured":"Arnold J, Holmes Z, Pickering W, Farmer C, Regan L, Cohen H (2001) Anti-beta 2 glycoprotein 1 and anti-annexin V antibodies in women with recurrent miscarriage. Br J Haematol 113:911\u2013914","journal-title":"Br J Haematol"},{"key":"3510_CR17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1538-7836.2009.03674.x","volume":"8","author":"V Pengo","year":"2010","unstructured":"Pengo V, Ruffatti A, Legnani C et al (2010) Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J Thromb Haemost 8:237\u2013242","journal-title":"J Thromb Haemost"},{"key":"3510_CR18","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/0961203310361485","volume":"19","author":"JH Rand","year":"2010","unstructured":"Rand JH, Wu XX, Quinn AS, Taatjes DJ (2010) The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis. Lupus 19:460\u2013469","journal-title":"Lupus"},{"key":"3510_CR19","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/clinchem\/47.6.1008","volume":"47","author":"J Nojima","year":"2001","unstructured":"Nojima J, Kuratsune H, Suehisa E et al (2001) Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. Clin Chem 47:1008\u20131015","journal-title":"Clin Chem"},{"key":"3510_CR20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ajh.2830470112","volume":"47","author":"J Matsuda","year":"1994","unstructured":"Matsuda J, Saitoh N, Gohchi K, Gotoh M, Tsukamoto M (1994) Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and\/or anticardiolipin antibody. Am J Hematol 47:56\u201358","journal-title":"Am J Hematol"},{"key":"3510_CR21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/(SICI)1096-8652(199703)54:3<209::AID-AJH6>3.0.CO;2-#","volume":"54","author":"J Kaburaki","year":"1997","unstructured":"Kaburaki J, Kuwana M, Yamamoto M, Kawai S, Ikeda Y (1997) Clinical significance of anti-annexin V antibodies in patients with systemic lupus erythematosus. Am J Hematol 54:209\u2013213","journal-title":"Am J Hematol"},{"key":"3510_CR22","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1196\/annals.1313.037","volume":"1050","author":"N Bizzaro","year":"2005","unstructured":"Bizzaro N, Antico A, Musso M et al (2005) A prospective study of 1038 pregnancies on the predictive value of anti-annexin V antibodies for fetal loss. Ann N Y Acad Sci 1050:348\u2013356","journal-title":"Ann N Y Acad Sci"},{"key":"3510_CR23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jri.2010.12.009","volume":"89","author":"MS Sater","year":"2011","unstructured":"Sater MS, Finan RR, Mustafa FE, Al-Khateeb GM, Almawi WY (2011) Anti-annexin V IgM and IgG autoantibodies and the risk of idiopathic recurrent spontaneous miscarriage. J Reprod Immunol 89:78\u201383","journal-title":"J Reprod Immunol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3510-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-016-3510-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3510-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T16:48:11Z","timestamp":1658249291000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-016-3510-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,21]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["3510"],"URL":"https:\/\/doi.org\/10.1007\/s10067-016-3510-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,21]]}}}